Alkem Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021
November 12, 2021 at 02:21 am EST
Share
Alkem Laboratories Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported sales was INR 27,999.9 million compared to INR 23,628 million a year ago. Revenue was INR 28,419.5 million compared to INR 23,983.4 million a year ago. Net income was INR 5,442.6 million compared to INR 4,720.6 million a year ago. Basic earnings per share from continuing operations was INR 45.52 compared to INR 39.48 a year ago. Diluted earnings per share from continuing operations was INR 45.52 compared to INR 39.48 a year ago.
For the six months, sales was INR 55,313.5 million compared to INR 43,548 million a year ago. Revenue was INR 56,199.6 million compared to INR 44,453.3 million a year ago. Net income was INR 10,123.8 million compared to INR 8,940.7 million a year ago. Basic earnings per share from continuing operations was INR 84.67 compared to INR 74.78 a year ago. Diluted earnings per share from continuing operations was INR 84.67 compared to INR 74.78 a year ago.
Alkem Laboratories Limited is an India-based company, which is engaged in the pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The Company offers its products across various therapeutic areas, such as Anti Infective, Dermatology, Diabetology, Cardiology, Gastroenterology, Osteoporosis, Rheumatology, central nervous system (CNS), Oncology, Urology, Gynecology, and Vitamins, Mineral and Nutrition. Its product range includes Rx Products, Alkem Generics and OTC Product. The Companyâs product portfolio includes brands, such as Clavam, Pan, Pan-D, Taxim-O, A To Z NS, Xone, Taxim, Gemcal, Pipzo and Ondem. The Company operates through a segment, Pharmaceuticals. It has approximately 21 manufacturing facilities at multiple locations in India and the United States. The Company has approximately 800 brands and operates in 40 countries.